Fluconazole resistant oral candidiasis in HIV positive patients;CANDIDOSES OROPHARYNGEES RESISTANTES AU FLUCONAZOLE CHEZ DES MALADES INFECTES PAR LE VIH

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 2, 1996, Pages 85-89

  Drobacheff, C ^a   Manteaux, A ^a   Millon, L ^a   Reboux, G ^a   Barale, Th ^a   Laurent, R ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ANTIFUNGAL AGENT;

ADULT; ARTICLE; CANDIDA ALBICANS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; ORAL DRUG ADMINISTRATION; THRUSH; AIDS RELATED COMPLEX; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DRUG RESISTANCE; FEMALE; FLUCONAZOLE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0029684907     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Monod M, Porchet S, Baudraz-Rosselet F, Frenk E. The identification of pathogenic yeast strains by electrophoretic analysis of their chromosomes. J Med Microbiol 1990;32:123-9.
2. Dupont B. Résistance de Candida aux antifongiques. EMC Inst Med 1987;58:23-6.
3. Galgiani IN. Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies. Rev Infect Dis 1990;12(suppl 3):272S-5S.
4. Druetta A, Freydiére A, Guinet R, Gille Y. Evaluation of five commercial antifungal susceptibility testing systems. Eur J Clin Microbiol Infect Dis 1993;12:336-42.
5. Dupouy-Camey J, Paugam A, Tourte-Schaefer C. Yeast susceptibility testing. Lancet 1991;338:383.
6. Fox R, Neal KR, Leen CLS, Ellis ME, Mandal BK. Fluconazole resistant Candida in AIDS. J Infect 1991;22:201-3.
7. Kitchen VS, Savage M, Harris JRW. Candida albicans resistance in AIDS. J Infect 1991;22:204-5.
8. Smith D, Boag F, Midgley J, Gazzard B. Fluconazole resistant Candida in AIDS. J Infect 1991;23:345-6.
9. Blumberg HM, Hender Shot EF, Lott TJ. Persistence of the same Candida albicans strain despite fluconazole therapy. Diagn Microbiol Infect 1992;15:545-7.
10. Dupouy-Camet J, Pangam A, Di Donate C, Kigure C, Kicens I, Volle PJ. Résistance au fluconazole en milieu hospitalier. Concordance entre la résistance de Candida albicans in vitro et l'échec thérapeutique. Presse Med 1991;20:1341.
11. Willocks L, Leen CLS, Brettle RP, Urguhart D, Russel TB, Milne LJR. Fluconazole resistance in AIDS patients. J Antimicrob Chemother 1991;28:937-9.
12. e Conférence européenne sur les aspects cliniques et le traitement de l'infection à VIH, Paris, 1992:32-114.
13. Adamski H, Michelet C, Guiguen C, Chevrier S, Dupont B, Cartier F. Relapses of oral candidiasis in HIV infected patients under fluconazole prophylaxis. 9th International Conference on AIDS, Berlin, 1993: PO-B09-1385, 366.
14. Heinic BS, Greenspan D, McPhail LA, Dodd CL, Beck C, Greenspan JS. Fluconazole resistant Candida in eight HIV seropositive patients. 9th International Conference on AIDS, Berlin, 1993: PO-B18-1808, 436.
15. Bailyg GG, Perry FM, Denning DW, Mandai BK. Fluconazole resistant in an HIV cohort. 9th International Conference on AIDS, Berlin, 1993: PO-B09-1358, 362.
16. Boken DJ, Swindells S, Rinaldi MG. Fluconazole resistant Candida albicans in HIV infection. 9th International Conference on AIDS, Berlin, 1993: PO-B09-1358, 362.
17. Reynes J, Pujol C, Renaud F, Mallie M, Janbon F, Bastide JM. Epidemiology of Candida albicans infection and fluconazole resistance: use of multilocus enzyme electrophoresis typing. 9th International Conference on AIDS, Berlin, 1993, WS-B12-1, 55.
18. Sangeorzan JA, Bradley SF, He X, Zarins LT, Ridenour GL, Tiballi RN, Kauffman CA. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994;97:339-46.
19. Redding S, Smith J, Farinacci G, Rinaldi M, Fothergill A, Rhine-Chalberg J, Pfaller M. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994;18:240-2.
20. Bart-Delabesse E, Boiron P, Carlotti A, Dupont B. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol 1993;31:2933-7.
21. Pfaller MA, Rhine-Chalberg J, Redding SW, Smith J, Farinacci G, Fothergill AW, Rinaldi MG. Varirations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994;32:59-64.
22. Odds FC. Resistance of yeasts to azole-derivative antifungals. J Antimicrob Chemother 1993;31:463-71.
23. Hitchcock CA, Barrett-Bee KJ, Russel NJ. The lipid composition and permeability to azole of an azole- and polyen-resistant mutant of Candida albicans. J Med Vet Mycol 1987;25:29-37.
24. Fan-Havard P, Capano D, Smith SM, Mangia A, Eng RHK. Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 1991;55:2302-5.
25. Dormont J. Prise en charge des personnes atteintes par le VIH. Paris: Flammarion Médecine-Sciences, 1993.
26. Ng TT, Denning DW. Fluconazole resistance in Candida in patients with AIDS: a therapeutic approach. J Infect 1993;26: 117-25.